Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessment of QSant™ for Underlying Allograft Rejection
Sponsor: NephroSant
Summary
The AQUA registry is a multi-center observational study to assess the clinical management of kidney transplant recipients (KTRs) with use of the QSant test. QSant is a test based on 6 urinary biomarkers including cell-free DNA, that is used for the evaluation and management of acute rejection in renal allograft recipients with clinical suspicion of rejection, as well as subclinical rejection.
Official title: Assessment of QSant™ for Underlying Allograft Rejection (AQUA Registry)
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
4000
Start Date
2023-03
Completion Date
2026-10
Last Updated
2022-09-28
Healthy Volunteers
No
Conditions
Interventions
QSant-TM Urine Test
QSant™ is a needle free urine test collected in-home or in-clinic to aid in the evaluation and management of kidney transplant recipients' allograft status. QSant evaluates 6 kidney-specific biomarkers.